Clemens, A., & Brückmann, M. (2014). Efficacy and cost-effectiveness of dabigatran etexilate versus warfarin in atrial fibrillation in different age subgroups. The American journal of cardiology, 114(6), .
Chicago-Zitierstil (17. Ausg.)Clemens, Andreas, und Martina Brückmann. "Efficacy and Cost-effectiveness of Dabigatran Etexilate Versus Warfarin in Atrial Fibrillation in Different Age Subgroups." The American Journal of Cardiology 114, no. 6 (2014).
MLA-Zitierstil (9. Ausg.)Clemens, Andreas, und Martina Brückmann. "Efficacy and Cost-effectiveness of Dabigatran Etexilate Versus Warfarin in Atrial Fibrillation in Different Age Subgroups." The American Journal of Cardiology, vol. 114, no. 6, 2014.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.